Daniel Payne - Latest News and Information
Technology Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
New: Small pharma companies are in talks with the White House to sign drug pricing deals of their own. Small companies will have to cut a deal in the next 180 days to fully avoid tariffs on branded drugs. https://t.co/XFalvi3i3D
Amid the Trump administration's focus on food, a key FDA leader briefs lawmakers on the agency's plans https://t.co/SrXI4ObmGF
Early details of what's in the White House's drug pricing bill text — and who's getting a sneak peek of it https://t.co/Yt8usm4yOa
The future of promising therapeutics is on the line in the Trump administration's FDA, says the agency's former commissioner https://t.co/vyt49FkDsb
Many interesting conversations ahead today at #STATBreakthrough — including on CMS and FDA, both at critical junctures: https://t.co/aThGw2QEfw
The Trump administration is "gearing up for war" to push Congress to codify its drug pricing policy — despite little appetite for it on the Hill. Still, the pharma industry sees risk in the back-and-forth. https://t.co/DR2LotvXFq
“We’re just kind of done with the vaccine issue,” said one White House official. “We’ve done what we want to do on the vaccine front.” On the future of the MAGA-MAHA alliance, w/ @ChelseaCirruzzo https://t.co/g6goE2TC6e
The American Academy of Pediatrics has become a leader in the effort to reverse RFK Jr.'s vaccine policies. The success — or failure — of the group's approach will have consequences for kids' health nationwide. Inside the AAP's plan for the MAHA...
